These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16459993)

  • 1. Tuberous sclerosis: a syndrome of incomplete tumor suppression.
    McCall T; Chin SS; Salzman KL; Fults DW
    Neurosurg Focus; 2006 Jan; 20(1):E3. PubMed ID: 16459993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex: genetics to pathogenesis.
    Narayanan V
    Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberous sclerosis complex: molecular pathogenesis and animal models.
    Piedimonte LR; Wailes IK; Weiner HL
    Neurosurg Focus; 2006 Jan; 20(1):E4. PubMed ID: 16459994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
    Govindarajan B; Brat DJ; Csete M; Martin WD; Murad E; Litani K; Cohen C; Cerimele F; Nunnelley M; Lefkove B; Yamamoto T; Lee C; Arbiser JL
    J Biol Chem; 2005 Feb; 280(7):5870-4. PubMed ID: 15576369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
    Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
    J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain lesions in tuberous sclerosis complex. Review.
    Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
    Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis complex and DNA repair.
    Habib SL
    Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.
    Boer K; Troost D; Jansen F; Nellist M; van den Ouweland AM; Geurts JJ; Spliet WG; Crino P; Aronica E
    Neuropathology; 2008 Dec; 28(6):577-90. PubMed ID: 18410267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.
    Suspitsin EN; Yanus GA; Dorofeeva MY; Ledashcheva TA; Nikitina NV; Buyanova GV; Saifullina EV; Sokolenko AP; Imyanitov EN
    J Hum Genet; 2018 May; 63(5):597-604. PubMed ID: 29476190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
    Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
    Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
    Gutmann DH; Zhang Y; Hasbani MJ; Goldberg MP; Plank TL; Petri Henske E
    Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
    Mizuguchi M; Ikeda K; Takashima S
    Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review.
    Jurca CM; Kozma K; Petchesi CD; Zaha DC; Magyar I; Munteanu M; Faur L; Jurca A; Bembea D; Severin E; Jurca AD
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cells: contradiction to two-hit model of tuber formation?
    Jozwiak J; Jozwiak S
    Cell Mol Neurobiol; 2007 Mar; 27(2):251-61. PubMed ID: 16897363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of tuberous sclerosis complex (TSC) protein function in the brain.
    Ramesh V
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):579-83. PubMed ID: 12773159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.